Antimalarial drug discovery targeting apical membrane antigen 1
نویسندگان
چکیده
منابع مشابه
Antimalarial drug discovery: targeting protein kinases.
Protein kinases (PKs) are prime targets for drug discovery in a variety of diseases, including cancer and neurodegenerative pathologies. The characterisation of the kinome of the human malaria parasite Plasmodium falciparum has revealed profound divergences, at several levels, between PKs of the parasite and those of its host. Here, the authors review the major issues and recent advances regard...
متن کاملAnalysis of Plasmodium vivax Apical Membrane Antigen-1 (PvAMA-1) Haplotypes among Iranian Isolates
Plasmodium vivax apical membrane antigen-1(PvAMA-1) is a surface protein with polymorphic sites. This study was aimed to analyze the polymorphic amino acid residues at PvAMA-1 in different infected age groups. 92 blood samples were collected from south and southeast of Iran. The DNA coding for the domain I (DI), DII, and partial DIII of this antigen was amplified by Nested-PCR, and sequenced. N...
متن کاملبررسی گلیکوزیلاسیون آنتی ژن (apical membrane antigen) ama1 در پلاسمودیوم فالسیپاروم
یک فرآیند مهم در چرخه زندگی پلاسمودیوم فالسیپاروم تهاجم به گلبولهای قرمز انسان است. ورود به سلولهای میزبان نیازمند آنتی ژن ama1 می باشد. بدلیل اینکه در یوکاریتوها آنتی بادیهایی که بر علیه این آنتی ژن ایجاد می شود می تواند مانع تهاجم شود بنابراین ama1 یکی از اهداف اولیه در تولید واکسن به شمار می رود. گفته می شود گلیکوزیلاسیون پروتئینهای سطحی در بسیاری از اعمال سلولی نظیر شناسایی سلولها سیگنالینگ...
15 صفحه اولAntimalarial drug discovery: old and new approaches.
New drugs against malaria are greatly needed. Many approaches to antimalarial drug discovery are available. These approaches must take into account specific concerns, in particular the requirement for very inexpensive and simple to use new therapies and the need to limit the cost of drug discovery. Among important efforts that are currently ongoing are the optimization of therapy with available...
متن کاملAntibody-drug conjugates targeting prostate-specific membrane antigen.
Prostate-specific membrane antigen (PSMA) is an integral, non-shed membrane glycoprotein that is a well-characterized and clinically validated marker of prostate cancer. The expression profile and other biological properties of PSMA make it an attractive target for antibody-drug conjugate (ADC) therapy of prostate cancer, as well as a broad range of other tumors in which PSMA is abundantly expr...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: MedChemComm
سال: 2017
ISSN: 2040-2503,2040-2511
DOI: 10.1039/c6md00495d